Solvay Wants Firms, Expert Removed In AndroGel Suit

Law360, New York (March 24, 2011, 6:05 PM EDT) -- Solvay Pharmaceuticals Inc. and two other drugmakers on Tuesday sought to disqualify an expert witness and two law firms from multidistrict litigation in Georgia over whether the companies' AndroGel patent settlements violated antitrust law.

Solvay says that Dr. Howard Maibach, who served as its consultant in the underlying patent litigation over the hormone drug, shared confidential information from that suit with the law firms of Heim Payne & Chorush LLP and Garwin Gerstein & Fisher LLP, according to a memorandum of law filed in the U.S....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.